Sivik Global Healthcare Acquires 20,000 Shares of Biogen

The institutional investor adds to its position in the biotechnology company

Apr. 8, 2026 at 11:36am

Got story updates? Submit your updates here. ›

Sivik Global Healthcare LLC, an institutional investor, has purchased a new position in shares of Biogen Inc. (NASDAQ:BIIB), acquiring 20,000 shares of the biotechnology company's stock during the fourth quarter. The shares are valued at approximately $3.52 million, representing 1% of Sivik Global Healthcare's holdings.

Why it matters

This transaction highlights the continued interest from institutional investors in Biogen, a leading biotechnology company known for its portfolio of multiple sclerosis treatments and other neurological therapies. The purchase by Sivik Global Healthcare reflects the firm's belief in Biogen's growth potential and the stock's long-term value.

The details

According to a recent SEC filing, Sivik Global Healthcare LLC purchased 20,000 shares of Biogen Inc. during the fourth quarter. The shares are valued at approximately $3.52 million, making Biogen the 29th largest position in Sivik Global Healthcare's investment portfolio.

  • Sivik Global Healthcare LLC purchased the 20,000 Biogen shares during the fourth quarter.

The players

Sivik Global Healthcare LLC

An institutional investor that has added a new position in shares of Biogen Inc.

Biogen Inc.

A multinational biotechnology company focused on discovering, developing, and delivering therapies for neurological and neurodegenerative diseases.

Got photos? Submit your photos here. ›

The takeaway

This transaction demonstrates the continued interest from institutional investors in Biogen, a leading player in the biotechnology industry. The purchase by Sivik Global Healthcare reflects the firm's belief in Biogen's growth potential and the stock's long-term value.